These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1141 related items for PubMed ID: 2262898

  • 1. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ, Tran LP.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [Abstract] [Full Text] [Related]

  • 2. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE, Ramkumar V, Lai WS.
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [Abstract] [Full Text] [Related]

  • 3. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart.
    Ehlert FJ, Delen FM, Yun SH, Friedman DJ, Self DW.
    J Pharmacol Exp Ther; 1989 Nov; 251(2):660-71. PubMed ID: 2810116
    [Abstract] [Full Text] [Related]

  • 4. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD, Annis SJ, Ehlert FJ, Leslie FM.
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [Abstract] [Full Text] [Related]

  • 5. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

  • 6. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 7. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [Abstract] [Full Text] [Related]

  • 8. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J, Marquez E, Laukkonen S, Martos F, Gómez A, Sánchez de la Cuesta F.
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [Abstract] [Full Text] [Related]

  • 9. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M, Waelbroeck M, Christophe J.
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [Abstract] [Full Text] [Related]

  • 10. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R, Probst A, Tobler HJ, Palacios JM.
    Brain Res; 1986 Jan 08; 362(2):239-53. PubMed ID: 3753655
    [Abstract] [Full Text] [Related]

  • 11. Evidence of paired M2 muscarinic receptors.
    Potter LT, Ballesteros LA, Bichajian LH, Ferrendelli CA, Fisher A, Hanchett HE, Zhang R.
    Mol Pharmacol; 1991 Feb 08; 39(2):211-21. PubMed ID: 1899905
    [Abstract] [Full Text] [Related]

  • 12. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR, Wolfe BB.
    Mol Pharmacol; 1984 Sep 08; 26(2):164-9. PubMed ID: 6548291
    [Abstract] [Full Text] [Related]

  • 13. Binding of [3H]AF-DX 384 to cloned and native muscarinic receptors.
    Miller JH, Gibson VA, McKinney M.
    J Pharmacol Exp Ther; 1991 Nov 08; 259(2):601-7. PubMed ID: 1941609
    [Abstract] [Full Text] [Related]

  • 14. Muscarinic M2 receptors in rat brain labeled with [3H] AF-DX 384.
    Castoldi AF, Fitzgerald B, Manzo L, Tonini M, Costa LG.
    Res Commun Chem Pathol Pharmacol; 1991 Dec 08; 74(3):371-4. PubMed ID: 1775727
    [Abstract] [Full Text] [Related]

  • 15. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB, Eubanks JH, Creese I.
    J Pharmacol Exp Ther; 1989 Mar 08; 248(3):1116-22. PubMed ID: 2703964
    [Abstract] [Full Text] [Related]

  • 16. Regional differences in the binding of selective muscarinic receptor antagonists in rat brain: comparison with minimum-energy conformations.
    Messer WS, Ellerbrock BR, Smith DA, Hoss W.
    J Med Chem; 1989 Jun 08; 32(6):1164-72. PubMed ID: 2724292
    [Abstract] [Full Text] [Related]

  • 17. Nicotine administration decreases the number of binding sites and mRNA of M1 and M2 muscarinic receptors in specific brain regions of rat neonates.
    Zhu J, Taniguchi T, Konishi Y, Mayumi M, Muramatsu I.
    Life Sci; 1998 Jun 08; 62(12):1089-98. PubMed ID: 9519811
    [Abstract] [Full Text] [Related]

  • 18. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
    Waelbroeck M, Gillard M, Robberecht P, Christophe J.
    Mol Pharmacol; 1987 Jul 08; 32(1):91-9. PubMed ID: 3600616
    [Abstract] [Full Text] [Related]

  • 19. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD, Mash DC.
    Synapse; 1993 Aug 08; 14(4):283-96. PubMed ID: 8248852
    [Abstract] [Full Text] [Related]

  • 20. A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini.
    Korc M, Ackerman MS, Roeske WR.
    J Pharmacol Exp Ther; 1987 Jan 08; 240(1):118-22. PubMed ID: 2433426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.